We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BGT.AU

Price
0.02
Stock movement up
+- (0.00%)
Company name
Bio-Gene Technology Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
7.02M
Ent value
6.40M
Price/Sales
74.67
Price/Book
4.31
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-3.13%
1 year return
-39.47%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-16

DIVIDENDS

BGT.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales74.67
Price to Book4.31
EV to Sales68.12

FINANCIALS

Per share

Loading...
Per share data
Current share count305.06M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.14M
Net receivables472.42K
Total current assets1.97M
Goodwill0.00
Intangible assets166.24K
Property, plant and equipment56.24K
Total assets2.15M
Accounts payable83.00K
Short/Current long term debt51.21K
Total current liabilities510.13K
Total liabilities522.98K
Shareholder's equity1.63M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.02
Daily high0.02
Daily low0.02
Daily Volume0K
All-time high0.34
1y analyst estimate0.37
Beta0.69
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date25 Feb 2026

Downside potential

Loading...
Downside potential data
BGT.AUS&P500
Current price drop from All-time high-93.24%-1.49%
Highest price drop-95.29%-19.00%
Date of highest drop30 Jun 20258 Apr 2025
Avg drop from high-90.85%-2.63%
Avg time to new high-6 days
Max time to new high302 days89 days
COMPANY DETAILS
BGT.AU (Bio-Gene Technology Ltd) company logo
Marketcap
7.02M
Marketcap category
Small-cap
Description
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications, as well as insect management in crop protection. The company was incorporated in 1995 and is based in Melbourne, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found